Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0060
-0.0007 (-10.45%)
At close: May 5, 2026
Evofem Biosciences Market Cap
Evofem Biosciences has a market cap or net worth of $795.18 thousand as of May 5, 2026. Its market cap has decreased by -24.16% in one year.
Market Cap
795.18K
Enterprise Value
60.11M
Revenue
20.18M
Ranking
n/a
PE Ratio
16.85
Stock Price
$0.01
Market Cap Chart
Since January 18, 2018, Evofem Biosciences's market cap has decreased from 215.21M to 795.18K, a decrease of -99.63%. That is a compound annual growth rate of -49.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 795.18K | -33.93% |
| Dec 31, 2025 | 1.20M | 7.24% |
| Dec 31, 2024 | 1.12M | -12.37% |
| Dec 29, 2023 | 1.28M | -83.76% |
| Dec 30, 2022 | 7.89M | -87.13% |
| Dec 31, 2021 | 61.26M | -68.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CERo Therapeutics Holdings | 1.25M |
| Eastgate Biotech | 1.06M |
| Adaptimmune Therapeutics | 1.03M |
| Windtree Therapeutics | 989.73K |
| Abpro Holdings | 959.29K |
| Eloxx Pharmaceuticals | 912.44K |
| Exousia Pro | 829.52K |
| Aibotics | 785.99K |